Yu-Ping Yang is a Principal Scientist II at Gilead Sciences, specializing in oncology research, translational medicine, and biomarker identification. With extensive experience in the fields of tumor biology, cancer stem cells, and preclinical models, they have played a significant role in advancing pharmacology programs and managing research teams. Previously, Yu-Ping held positions at CytomX Therapeutics as a Senior Scientist focused on clinical biomarkers, as well as at AbbVie and Vanderbilt University Medical Center. They are currently pursuing a Ph.D. in Genetics and Genomics at Duke University, alongside an M.S. in Cellular and Molecular Biology and a B.S. in Life Sciences from National Taiwan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices